H.C. Wainwright Reiterates Buy Rating on Eupraxia Pharmaceuticals (EPRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: EPRX) | Delayed: 6.87 -0.72 (9.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.59 | 52 Week High | $ | |||
| Open | $7.51 | 52 Week Low | $ | |||
| Day High | $7.61 | P/E | N/A | |||
| Day Low | $6.70 | EPS | $ | |||
| Volume | 348,797 | |||||
